CA1273014A - Carbapenem process - Google Patents

Carbapenem process

Info

Publication number
CA1273014A
CA1273014A CA000506668A CA506668A CA1273014A CA 1273014 A CA1273014 A CA 1273014A CA 000506668 A CA000506668 A CA 000506668A CA 506668 A CA506668 A CA 506668A CA 1273014 A CA1273014 A CA 1273014A
Authority
CA
Canada
Prior art keywords
alkyl
formula
phenyl
group
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000506668A
Other languages
English (en)
French (fr)
Inventor
Pierre Dextraze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of CA1273014A publication Critical patent/CA1273014A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA000506668A 1985-04-29 1986-04-15 Carbapenem process Expired - Lifetime CA1273014A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72800985A 1985-04-29 1985-04-29
US728,009 1985-04-29

Publications (1)

Publication Number Publication Date
CA1273014A true CA1273014A (en) 1990-08-21

Family

ID=24925057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000506668A Expired - Lifetime CA1273014A (en) 1985-04-29 1986-04-15 Carbapenem process

Country Status (12)

Country Link
KR (1) KR860008183A (cs)
CA (1) CA1273014A (cs)
CS (1) CS261240B2 (cs)
DK (1) DK193886A (cs)
ES (1) ES8706671A1 (cs)
FI (1) FI861721A7 (cs)
GR (1) GR861150B (cs)
HU (1) HU197904B (cs)
LU (1) LU86410A1 (cs)
NO (1) NO861667L (cs)
OA (1) OA08240A (cs)
YU (1) YU150986A (cs)

Also Published As

Publication number Publication date
ES8706671A1 (es) 1987-07-01
HU197904B (en) 1989-06-28
YU150986A (en) 1987-12-31
DK193886A (da) 1986-10-30
CS261240B2 (en) 1989-01-12
DK193886D0 (da) 1986-04-28
GR861150B (en) 1986-09-02
FI861721A0 (fi) 1986-04-24
CS311886A2 (en) 1988-04-15
HUT41792A (en) 1987-05-28
FI861721A7 (fi) 1986-10-30
ES554468A0 (es) 1987-07-01
LU86410A1 (fr) 1986-11-05
OA08240A (en) 1987-10-30
NO861667L (no) 1986-10-30
KR860008183A (ko) 1986-11-12

Similar Documents

Publication Publication Date Title
EP0272455B1 (en) 3-Pyrrolidinylthio-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic acid compounds
CA1273009A (en) Carbapenem antibiotics
EP0090366B1 (en) 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE69129175T2 (de) 1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung
SE463514B (sv) Foerfarande foer framstaellning av penemderivat
EP0055990A1 (en) Beta-lactam antibiotics, their preparation and use
CA1283659C (en) Carbapenem antibiotics
DE3688087T2 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
CA1269978A (en) Carbapenem antibiotics
CA1284324C (en) Carbapenem process
CA1273014A (en) Carbapenem process
CA1272719A (en) Carbapenem antibiotics
CA2069764A1 (en) Tetracyclic antibiotics and processes for their preparation
US4640799A (en) Carbapenem antibiotics
CA2048279A1 (en) 2-(9-fluorenonyl)-carbapenem
KR870001743B1 (ko) 카바펜엠 항생제의 제조방법
DE3788369T2 (de) Verfahren zur Herstellung von Cephalosporinderivaten.
CA1178278A (en) .beta.-LACTAM ANTIBIOTICS, THEIR PREPARATION AND USE
WO1994005667A1 (en) Carbapenem derivatives and processes for preparing the same
EP0018155A2 (en) Novel cephalosporin compounds, a process for the preparation thereof, pharmaceutical compositions containing the same and the use thereof as a therapeutic agent against a microorganism
JPH1045758A (ja) カルバペネム化合物、その製造法および剤
JPS5910588A (ja) カルバペネム抗生物質
CA2045432A1 (en) 2-phenanthrenyl-carbapenem antibacterial agents
JPH075598B2 (ja) 2−(n−イミダゾリウムフエニル)カルバペネム
JPS5931791A (ja) 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤

Legal Events

Date Code Title Description
MKLA Lapsed